IRCT20200105046010N18招募中未知
Pharmacokinetic assessments of YUNIMIDE® tablet with brand drugs VIMPAT®200mg UCB Pharma, Belgium
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •General health
- •Body mass index(18-28)
- •Informed consent
- •Age(18-60)
排除标准
- •A history of cardiovascular disease
- •A history of liver & kidney disease
- •Alcohol & Drug addiction
- •Hypersensitivity to the drug
研究者
相似试验
进行中（未招募）
1 期
Pharmacokinetic and pharmacodynamic evaluation of linezolid administered intravenously in MRSA-positive, morbidly obese patients with pneumonia.EUCTR2012-005127-33-BEniversity Ghent20
尚未招募
不适用
In-vivo Bioequivalence Test Fampridine tablet with brand drug FAMPYRA Made by Biogen Idec, UK.The aim of this study is evaluation of bioequivalence of test and reference drugs and the study will one by healthy volunteers.IRCT20200105046010N19Pharan shimi Pharmaceutical Company24
已完成
不适用
Pharmacokinetic and pharmacodynamic profile of midazolam intranasal spray in elderly volunteers.NL-OMON49143QPS Netherlands B.V.12
进行中（未招募）
不适用
Pharmacokinetic evaluation of a new formulation of recombinant factor IX (BeneFIX) in the italian population with severe or moderate B haemophilia previously treated. - NDPatients with severe or moderate B Haemophilia, previously treated with rFIX.MedDRA version: 9.1Level: SOCClassification code 10010331EUCTR2008-006465-85-ITAZIENDA OSPEDALIERA UNIVERSITARIA CAREGGI
进行中（未招募）
不适用
Evaluation of pharmacokinetic and pharmacodynamic interactions between escitalopram and drugs used for the treatment of bipolar disorders. - NDbipolar disordersMedDRA version: 9.1Level: LLTClassification code 10057667Term: Bipolar disorderEUCTR2008-000370-20-ITAZIENDA OSPEDALIERA PISANA